๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metabolism and pharmacokinetics of 1,3-butadiene

โœ Scribed by Linda S. Birnbaum; Douglas A. Keller


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
253 KB
Volume
113
Category
Article
ISSN
0300-483X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Metabolism of 1,3-butadiene: species dif
โœ Rogene F. Henderson; Janice R. Thornton-Manning; William E. Bechtold; Alan R. Da ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 476 KB
Species differences in butadiene metabol
โœ R. Kreiling; R. J. Laib; J. G. Filser; H. M. Bolt ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 456 KB

Metabolism of 1,3-butadiene to 1,2-epoxybutene-3 in rats follows saturation kinetics. Comparative investigation of inhalation pharmacokinetics in mice also revealed a saturation pattern. For both species "linear" pharmacokinetics apply at exposure concentrations below 1000 ppm 1,3-butadiene; saturat

Pharmacokinetics and metabolism of encai
โœ Patrice Jaillon ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 404 KB

The metabolism of encainide occurs in the liver and is polymorphically distributed according to the same genetic factor that determines the 4-hydroxylation of debrisoquine. Over 90% of patients are extensive metabolizers (EM) in whom the oral bioavailability of encainide is only 30% because of exten